151 related articles for article (PubMed ID: 6498389)
1. Long term follow-up in cutaneous malignant melanoma: the relationship of maximal tumour thickness to disease free survival, disease recurrence and death.
Griffiths RW; Briggs JC
Br J Plast Surg; 1984 Oct; 37(4):507-13. PubMed ID: 6498389
[TBL] [Abstract][Full Text] [Related]
2. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
3. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
[TBL] [Abstract][Full Text] [Related]
4. Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I).
Milton GW; Shaw HM; Farago GA; McCarthy WH
Br J Surg; 1980 Aug; 67(8):543-6. PubMed ID: 7427045
[TBL] [Abstract][Full Text] [Related]
5. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.
Reintgen DS; Cox C; Slingluff CL; Seigler HF
Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405
[TBL] [Abstract][Full Text] [Related]
6. [Axillary recurrence after lymph node excision in malignant melanoma].
Kretschmer L; Lautenschläger C; Preusser KP; Fiedler H; Hetschko I
Langenbecks Arch Chir; 1993; 378(1):4-11. PubMed ID: 8437502
[TBL] [Abstract][Full Text] [Related]
7. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study.
McCarthy WH; Shaw HM; Thompson JF; Milton GW
Surg Gynecol Obstet; 1988 Jun; 166(6):497-502. PubMed ID: 3375961
[TBL] [Abstract][Full Text] [Related]
8. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
9. Early-stage non-Spitzoid cutaneous melanoma in patients younger than 22 years of age at diagnosis: long-term follow-up and survival analysis.
Stanelle EJ; Busam KJ; Rich BS; Christison-Lagay ER; Dunkel IJ; Marghoob AA; Halpern A; Coit DG; La Quaglia MP
J Pediatr Surg; 2015 Jun; 50(6):1019-23. PubMed ID: 25819019
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
11. Conditional Survival-Based "Abbreviated" Routine Cancer Surveillance for Pathologic Stage IB Melanoma.
Kukar M; Gabriel E; May R; Cho E; Lichtenthal M; Groman A; Skitzki J; Francescutti V; Kane JM
Am Surg; 2017 Nov; 83(11):1256-1262. PubMed ID: 29183528
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of thick cutaneous melanoma of the trunk and extremity.
Coit D; Sauven P; Brennan M
Arch Surg; 1990 Mar; 125(3):322-6. PubMed ID: 2306180
[TBL] [Abstract][Full Text] [Related]
13. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
14. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
[TBL] [Abstract][Full Text] [Related]
16. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
17. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
18. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
19. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
Tas F; Erturk K
Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
[TBL] [Abstract][Full Text] [Related]
20. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]